Q4 results of Smith&Nephew, NuVASIVE
Spine bussiness is meeting solid milestones
Smith & Nephew, new leadership resulted in 7 % rise in stock
NuVasive expected to grow 4 - 6 % in 2020
source: Medtechdive
16 views
Search
Recent Posts
See AllJust one day after Abbott receives an FDA EUA ("emergency use authorization") - $760M contract from HHS for 150M antigen tests - tests are meant for schools and vulnerable populations - Abbott being t
Abbott gets EUA; COVID-19 antigen test #covid19test#antigen#covid19 Already in the antigen game - BD / Quidel / LumiraDx Abbott`s USP = scale + price scale - Abbott: 50 M / month by October - BD: 8 M